MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-20-0059988
Sanvas Pharma Private Limited
Sanvas Pharma Private Limited - healthcare in Nagpur, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹3.41 Lakh
▲ 395% YoY
Net loss · FY 2025
₹1.41 Lakh
Net margin -41.3%
EBITDA · FY 2025
-₹1.36 Lakh
EBITDA margin -39.9%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
7 yrs
Est. 2019
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Sanvas Pharma Private Limited
Data last updated:
Sanvas Pharma Private Limited is a private limited company based in Nagpur, Maharashtra, India. It operates in the preventive healthcare segment of the healthcare sector. It was incorporated on 08 February 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51100MH2019PTC320827. Its GSTIN is 27ABBCS5610B1ZT (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Santosh Pundlikrao Khobragade and Saurabh Santosh Khobragade.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H.No.2708/A/17 Gadge Baba Nagar, Nagpur, Maharashtra, India – 440009.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.41 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹1.41 Lakh (net margin -41.3%) and EBITDA of -₹1.36 Lakh (EBITDA margin -39.9%). Revenue has grown at a compounded annual rate (CAGR) of 11% over three years.
Sanvas Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-20-0059988). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U51100MH2019PTC320827
Registration Number 320827
Incorporation Date 08 February 2019
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MH-20-0059988
CIN history
Sanvas Pharma has one previous CIN (Corporate Identification Number): U80903MH2019PTC320827. The current CIN is U51100MH2019PTC320827, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U51100MH2019PTC320827 | Current |
| U80903MH2019PTC320827 | Previous |
Recognitions & Rankings of Sanvas Pharma
Contact details
Sanvas Pharma Private Limited's registered office is in Nagpur, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressH.No.2708/A/17 Gadge Baba Nagar, Nagpur, Maharashtra, India – 440009
- IndustryHealthcare, Preventive Health Services
To see the full contact details of Sanvas Pharma Private Limited, buy the company report.
Comprehensive company report
Sanvas Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Sanvas Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Sanvas Pharma Private Limited, buy the company report.
Financials of Sanvas Pharma Private Limited
FY 2025 filings availableSanvas Pharma Private Limited reported revenue of ₹3.41 Lakh (up 395% YoY) for FY 2025.
Revenue · FY 2025
₹3.41 Lakh ▲ 395%
Net loss · FY 2025
₹1.41 Lakh margin -41.3%
EBITDA · FY 2025
-₹1.36 Lakh margin -39.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 395%
3 years · compounded
▲ 11%
EBITDA CAGR growth
1 year
▼ 68%
3 years · compounded
▼ 145%
5 years · compounded
▼ 69%
Revenue has grown at a compounded annual rate (CAGR) of 11% over three years, including 395% growth in the latest year. EBITDA fell 68% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1.36 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.41 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -39.9% | ||||
| Net Profit Margin | -41.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sanvas Pharma Private Limited, buy the company report.
Board of directors of Sanvas Pharma Private Limited
Sanvas Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Santosh Pundlikrao Khobragade | Director | 15 Feb 2020 | 6 Years 8 Months | Current |
| Saurabh Santosh Khobragade | Director | 08 Feb 2019 | 7 Years 8 Months | Current |
Legal cases
No court or tribunal cases involving Sanvas Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sanvas Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Sanvas Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27ABBCS5610B1ZT | Maharashtra | Active | 31 Dec 2021 |
To see the full GST registrations and return filing status of Sanvas Pharma Private Limited, buy the company report.
Recent activity
Sanvas Pharma Private Limited has 4 board changes on record since 2019: 2 appointments and 2 cessations. The latest: Santosh Pundlikrao Khobragade was appointed as Director on 15 Feb 2020.
AGM
Sanvas Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Sanvas Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Appointed
Santosh Pundlikrao Khobragade was appointed as Director.
Ceased
Mayur Bhimrao Kale ceased to be Director.
Ceased
Prabhat Jain ceased to be Director.
Appointed
Saurabh Santosh Khobragade was appointed as Director.
Incorporation
08 Feb 2019
Sanvas Pharma Private Limited was registered on 08 Feb 2019 with Roc Mumbai & aged 7 years 8 months as per MCA records.
Frequently asked questions
Sanvas Pharma is an active private limited company based in Nagpur, Maharashtra, India. The company works in preventive health services, within the healthcare industry. It was incorporated on 08 February 2019 (7+ years old) and is registered under CIN U51100MH2019PTC320827.
Sanvas Pharma has 2 current directors:
- Santosh Pundlikrao Khobragade - Director
- Saurabh Santosh Khobragade - Director
The latest financial statements of Sanvas Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Sanvas Pharma is 27ABBCS5610B1ZT, registered in Maharashtra.
The CIN (Corporate Identification Number) of Sanvas Pharma is U51100MH2019PTC320827. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sanvas Pharma was incorporated on 08 February 2019, making it 7+ years old. It is registered with the Registrar of Companies, Mumbai.
Santosh Pundlikrao Khobragade was appointed as Director on 15 Feb 2020. Mayur Bhimrao Kale ceased to be Director on 22 Jan 2020. Prabhat Jain ceased to be Director on 22 Jan 2020. Sanvas Pharma has 4 board changes on record in total.
Yes, Sanvas Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-20-0059988).
The registered office of Sanvas Pharma is at H.No.2708A17 Gadge Baba Nagar, Nagpur, Maharashtra, India – 440009.
Sanvas Pharma operates in the healthcare industry, in the preventive health services segment.